Francesca Polistena
Overview
Explore the profile of Francesca Polistena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Micarelli D, Duca I, Tartaglione L, Frassetti N, Coppola B, Polistena F, et al.
G Ital Nefrol
. 2022 Apr;
39(2).
PMID: 35471001
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare systemic vasculitis. Rapidly progressive glomerulonephritis (RPGN) is a rare complication of EGPA. We report a case of...
2.
Pistolesi V, Zeppilli L, Polistena F, Sacco M, Pierucci A, Tritapepe L, et al.
Blood Purif
. 2017 Feb;
44(1):8-15.
PMID: 28219057
Aims: To evaluate the efficacy and safety of a commercially available phosphate-containing solution for continuous renal replacement therapy (CRRT) in preventing CRRT-related hypophosphatemia. Methods: In heart surgery patients undergoing continuous...
3.
Pistolesi V, Di Napoli A, Fiaccadori E, Zeppilli L, Polistena F, Sacco M, et al.
J Nephrol
. 2015 May;
29(2):229-239.
PMID: 26022723
Background: Acute kidney injury (AKI) represents a major complication of cardiac surgery. Our aim was to evaluate, in patients undergoing continuous renal replacement therapy (CRRT) for cardiac surgery-associated AKI (CS-AKI),...
4.
Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al.
Int J Artif Organs
. 2013 Dec;
36(12):845-52.
PMID: 24362894
Purpose: The need for prolonged anticoagulation and the occurrence of hypophosphatemia are well known drawbacks of continuous renal replacement therapies (CRRT). The aim was to evaluate the effects on acid-base...
5.
Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al.
BMC Nephrol
. 2013 Oct;
14:232.
PMID: 24156306
Background: Recent guidelines suggest the adoption of regional citrate anticoagulation (RCA) as first choice CRRT anticoagulation modality in patients without contraindications for citrate. Regardless of the anticoagulation protocol, hypophosphatemia represents...
6.
Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Fiaccadori E, et al.
Hemodial Int
. 2012 Aug;
17(2):313-20.
PMID: 22882732
Regional citrate anticoagulation (RCA) is a valid anticoagulation method in continuous renal replacement therapies (CRRT) and different combination of citrate and CRRT solutions can affect acid-base balance. Regardless of the...
7.
Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, et al.
Crit Care
. 2012 Jun;
16(3):R111.
PMID: 22738289
Introduction: Regional citrate anticoagulation (RCA) is a valid option in patients at high risk of bleeding who are undergoing continuous renal replacement therapy (CRRT). The aim of this study was...
8.
Morabito S, Pistolesi V, Benedetti G, Di Roma A, Colantonio R, Mancone M, et al.
J Nephrol
. 2012 Mar;
25(6):1098-107.
PMID: 22383347
Background: Contrast-induced acute kidney injury (CI-AKI) represents an important cause of hospital-acquired AKI. The aim of this study was to evaluate the incidence of CI-AKI after coronary angiography (CA) or...